Federated Hermes Portfolio holdings
Federated Hermes is an investment manager that runs mutual funds, ETFs and other portfolios across stocks, bonds, alternative and private markets and liquidity management. It began in 1955 as Federated Investors, set up by three high school classmates: John F. Donahue, Thomas J. Donnelly and Richard B. Fisher. In 2018 the firm bought a majority stake in Hermes Fund Managers, which ran Hermes Investment Management, from the BT Pension Scheme. In 2020 Federated Investors renamed itself Federated Hermes. Its clients include corporations, government entities, insurance companies, foundations, endowments, banks and brokerages.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$436M |
| 2 |
Regions Financial
RF
|
+$313M |
| 3 |
Automatic Data Processing
ADP
|
+$289M |
| 4 |
Intuit
INTU
|
+$288M |
| 5 |
Netflix
NFLX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 2 |
Teradyne
TER
|
+$320M |
| 3 |
Truist Financial
TFC
|
+$313M |
| 4 |
UnitedHealth
UNH
|
+$287M |
| 5 |
Huntington Bancshares
HBAN
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.03% |
| 2 | Healthcare | 13.59% |
| 3 | Industrials | 13.09% |
| 4 | Financials | 10.33% |
| 5 | Consumer Discretionary | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
751
Madrigal Pharmaceuticals
MDGL
$9.9B
| $8.01M | 0.01% |
14,914
-1,989
| -12% | -$1.02M |
2025 Q3
3 quarters
|
|
752
EPAM Systems
EPAM
$7.25B
| $7.99M | 0.01% |
100,647
-36,964
| -27% | -$3.91M |
2020 Q3
23 quarters
|
|
753
First Business Financial Services
FBIZ
$628M
| $7.93M | 0.01% |
125,563
+9,430
| +8% | +$546K |
2014 Q2
48 quarters
|
|
754
Neighborhood Intelligence Inc
NXH
$168M
| $7.93M | 0.01% |
1,369,753
+386,922
| +39% | +$2.12M |
2022 Q2
16 quarters
|
|
755
LeMaitre Vascular
LMAT
$1.85B
| $7.91M | 0.01% |
82,468
+21,041
| +34% | +$2.16M |
2015 Q3
43 quarters
|
|
756
Voyager Technologies
VOYG
$1.61B
| $7.9M | 0.01% |
245,100
-93,900
| -28% | -$3.25M |
2025 Q2
4 quarters
|
|
757
The Elmet Group
ELMT
$706M
| $7.9M | 0.01% |
+400,000
| New | +$6.87M |
2026 Q2
0 quarters
|
|
758
Rocket Pharmaceuticals
RCKT
$268M
| $7.88M | 0.01% |
2,304,207
+1,280,460
| +125% | +$4.26M |
2025 Q1
5 quarters
|
|
759
Stanley Black & Decker
SWK
$15.6B
| $7.79M | 0.01% |
82,727
+7,142
| +9% | +$560K |
2022 Q3
15 quarters
|
|
760
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
$4.24B
| $7.79M | 0.01% |
65,273
| – | – |
2024 Q3
7 quarters
|
|
761
Dell
DELL
$270B
| $7.77M | 0.01% |
18,005
-270,120
| -94% | -$78.1M |
2016 Q3
39 quarters
|
|
762
AstraZeneca
AZN
$289B
| $7.66M | 0.01% |
40,408
-3,177
| -7% | -$598K |
2013 Q2
52 quarters
|
|
763
Otis Worldwide
OTIS
$28.8B
| $7.63M | 0.01% |
106,593
+303
| +0.3% | +$22.6K |
2020 Q2
24 quarters
|
|
764
Spyre Therapeutics
SYRE
$9.02B
| $7.63M | 0.01% |
+85,950
| New | +$6.27M |
2026 Q2
0 quarters
|
|
765
Phinia Inc
PHIN
$2.26B
| $7.6M | 0.01% |
92,282
-1,456
| -2% | -$111K |
2023 Q3
11 quarters
|
|
766
Phillips Edison & Co
PECO
$5.01B
| $7.57M | 0.01% |
+181,848
| New | +$7.26M |
2026 Q2
0 quarters
|
|
767
California Water Service
CWT
$3.05B
| $7.55M | 0.01% |
155,114
+25,923
| +20% | +$1.17M |
2024 Q3
7 quarters
|
|
768
Keros Therapeutics
KROS
$219M
| $7.49M | 0.01% |
700,427
+11,198
| +2% | +$125K |
2024 Q4
6 quarters
|
|
769
Kennametal
KMT
$2.22B
| $7.49M | 0.01% |
213,670
+45,615
| +27% | +$1.66M |
2013 Q2
52 quarters
|
|
770
CoreCivic
CXW
$3.05B
| $7.46M | 0.01% |
245,710
-7,966
| -3% | -$181K |
2025 Q2
4 quarters
|
|
771
Fidelity National Financial
FNF
$10.9B
| $7.45M | 0.01% |
157,944
-6,492
| -4% | -$314K |
2021 Q2
20 quarters
|
|
772
Noble Corp
NE
$7.82B
| $7.38M | 0.01% |
+197,918
| New | +$9.46M |
2026 Q2
0 quarters
|
|
773
Ecolab
ECL
$85B
| $7.38M | 0.01% |
26,488
-13
| -0% | -$3.42K |
2013 Q2
52 quarters
|
|
774
Booz Allen Hamilton
BAH
$10.5B
| $7.35M | 0.01% |
121,088
-40,948
| -25% | -$3.13M |
2022 Q3
15 quarters
|
|
775
Frontdoor
FTDR
$6.04B
| $7.3M | 0.01% |
94,029
+86,507
| +1,150% | +$5.53M |
2022 Q2
16 quarters
|
|
Similar funds
Federated Hermes's Q2 2026 Portfolio in Review
As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
- Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
- Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
- Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
- Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
- Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
- Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.